Carl Zeiss Meditec AG
XETRA:AFX

Watchlist Manager
Carl Zeiss Meditec AG Logo
Carl Zeiss Meditec AG
XETRA:AFX
Watchlist
Price: 69 EUR 7.9% Market Closed
Market Cap: 6.2B EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
-9%
Revenue
Forecast
+8%
Operating Income
Forecast
+26%
Net Income
Forecast
+15%

Wall Street
Price Targets

AFX Price Targets Summary
Carl Zeiss Meditec AG

Wall Street analysts forecast AFX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFX is 62.49 EUR with a low forecast of 50.5 EUR and a high forecast of 94.5 EUR.

AFX Lowest Forecast
Wall Street Target
50.5 EUR
27% Downside
AFX Average Forecast
Wall Street Target
62.49 EUR
9% Downside
AFX Highest Forecast
Wall Street Target
94.5 EUR
37% Upside
Lowest
Price Target
50.5 EUR
27% Downside
Average
Price Target
62.49 EUR
9% Downside
Highest
Price Target
94.5 EUR
37% Upside
Carl Zeiss Meditec AG Competitors:
Price Targets
NARI
Inari Medical Inc
5% Downside
O
OPTOMED
Optomed Oyj
35% Upside
6609
Shanghai HeartCare Medical Technology Corp Ltd
35% Downside
LMAT
LeMaitre Vascular Inc
27% Upside
NARI
Inari Medical Inc
5% Downside
O
OPTOMED
Optomed Oyj
35% Upside
6609
Shanghai HeartCare Medical Technology Corp Ltd
35% Downside
LMAT
LeMaitre Vascular Inc
27% Upside
AXGN
AxoGen Inc
40% Upside
PRN
Profound Medical Corp
164% Upside
IDXX
IDEXX Laboratories Inc
25% Upside
P
FNA
Paragon 28 Inc
10% Upside

Revenue
Forecast

Revenue Estimate
Carl Zeiss Meditec AG

For the last 8 years the compound annual growth rate for Carl Zeiss Meditec AG's revenue is 8%. The projected CAGR for the next 3 years is 8%.

8%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Carl Zeiss Meditec AG

For the last 8 years the compound annual growth rate for Carl Zeiss Meditec AG's operating income is 3%. The projected CAGR for the next 3 years is 26%.

3%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Carl Zeiss Meditec AG

For the last 8 years the compound annual growth rate for Carl Zeiss Meditec AG's net income is 8%. The projected CAGR for the next 3 years is 15%.

8%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

See Also

Summary
AFX intrinsic value, competitors valuation, and company profile.
DCF Valuation
AFX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AFX stock valuation using valuation multiples.
Wall Street Estimates
AFX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AFX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AFX's stock price target?
Price Target
62.49 EUR

According to Wall Street analysts, the average 1-year price target for AFX is 62.49 EUR with a low forecast of 50.5 EUR and a high forecast of 94.5 EUR.

What is Carl Zeiss Meditec AG's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Carl Zeiss Meditec AG's revenue is 8%. The projected CAGR for the next 3 years is 8%.

What is Carl Zeiss Meditec AG's Operating Income forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for Carl Zeiss Meditec AG's operating income is 3%. The projected CAGR for the next 3 years is 26%.

What is Carl Zeiss Meditec AG's Net Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Carl Zeiss Meditec AG's net income is 8%. The projected CAGR for the next 3 years is 15%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.